Beau Webber

Company: Luminary Therapeutics

Job title: Chief Science Officer & Founder

Seminars:

GDT & CAR-T Preclinical Dual Targeting & Engineering Gamma Delta Cells 4:30 pm

Novel set of CARs that address challenges head on for both hematological malignancy and sold tumors Our solid tumor program utilizes a Dual CAR architecture to target multiple cancer antigens and more completely eradicate cancerous cells with a single engineered T cell product Establish an allogeneic dual targeting CAR that will consist of CSPG4 and…Read more

day: Conference Day One